Knee flexion contracture treated with botulinum toxin type A in patients with haemophilia (PWH)

Haemophilia. 2016 Jan;22(1):134-41. doi: 10.1111/hae.12745. Epub 2015 Jul 17.

Abstract

Introduction: Knee flexion contracture (KFC) remains a common complication of haemoarthrosis in children and young adults with haemophilia. If the KFC is not treated properly it produces disability, postural and gait abnormalities.

Objective: Evaluate the effectiveness of conservative treatment of KFC with Botulinum toxin type A (BTX-A) in PWH.

Methods: Seventeen patients were treated, with 21 affected knees. Mean age was 26 years. The mean follow up was 12 months. We evaluated flexion and KFC pretreatment BTX-A and up to 12 months posttreatment. BTX-A application was in hamstring and calf muscles. To evaluate the function, a questionnaire about different activities was made, and it was checked 3, 6 and 12 months after BTX-A. According to the degree of KFC, knees were divided into 3 groups: Group 1: -10° to -30° (n = 10), Group 2: -31° to -45° (n = 6) Group 3: -46° or more (n = 5).

Results: The average KFC improved from -38° to -24°. The improvement was 14° (P < 0.001). The average KFC improvement was 9° in group 1, 17° in group 2, and 23° in group 3. There was a high correlation between the improvement in KFC and the total score of the questionnaire R = 0.77.

Conclusions: Treatment of KFC with BTX-A improves knee-related functional activities, with the advantage of being a low-cost procedure and easy to apply.

Keywords: botulinum toxin type A; haemophilia; knee flexion contracture.

MeSH terms

  • Adolescent
  • Adult
  • Botulinum Toxins, Type A / pharmacology
  • Botulinum Toxins, Type A / therapeutic use*
  • Child
  • Contracture / complications*
  • Contracture / drug therapy*
  • Contracture / physiopathology
  • Hemophilia A / complications*
  • Humans
  • Knee Joint / drug effects*
  • Knee Joint / physiopathology*
  • Middle Aged
  • Range of Motion, Articular / drug effects*
  • Recovery of Function / drug effects
  • Surveys and Questionnaires
  • Young Adult

Substances

  • Botulinum Toxins, Type A